Wolverine Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-84,600
Closed -$5.42M 1936
2018
Q4
$5.42M Buy
84,600
+2,100
+3% +$155K 0.07% 274
2018
Q3
$7.38M Hold
82,500
0.09% 229
2018
Q2
$6.55M Buy
82,500
+24,300
+42% +$2.02M 0.08% 230
2018
Q1
$5.19M Buy
58,200
+56,700
+3,780% +$5.44M 0.07% 266
2017
Q4
$156K Buy
+1,500
New +$169K ﹤0.01% 1107
2016
Q4
Sell
-7,600
Closed -$794K 1460
2016
Q3
$794K Buy
7,600
+6,500
+591% +$703K 0.01% 613
2016
Q2
$108K Buy
+1,100
New +$114K ﹤0.01% 973
2016
Q1
Sell
-42
Closed -$233K 1924
2015
Q4
$233K Hold
42
0.01% 820
2015
Q3
$183K Hold
42
﹤0.01% 940
2015
Q2
$217K Hold
42
﹤0.01% 878
2015
Q1
$220K Sell
42
-746
-95% -$89.1K ﹤0.01% 830
2014
Q4
$4.68M Sell
788
-8
-1% -$844 0.09% 171
2014
Q3
$3.47M Sell
796
-108
-12% -$9.75K 0.07% 208
2014
Q2
$3.06M Buy
904
+214
+31% +$16.3K 0.07% 214
2014
Q1
$1.7M Sell
690
-602
-47% -$47.7K 0.04% 311
2013
Q4
$5.45M Sell
1,292
-200
-13% -$15.8K 0.11% 162
2013
Q3
$4.58M Sell
1,492
-100
-6% -$7.01K 0.1% 172
2013
Q2
$2.64M Buy
+1,592
New +$95.8K 0.07% 247

Other funds holding CELG

Wolverine Asset Management's CELG Position: Q4 2019 in Review

Wolverine Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 71,469 shares — an estimated $7.1M sold.

Wolverine Asset Management first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $27.3M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Wolverine Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Wolverine Asset Management sold 71,469 Celgene Corp shares in Q4 2019, an estimated $7.1M.
  • Wolverine Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
  • Wolverine Asset Management's Celgene Corp position peaked at $27.3M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Wolverine Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.